Yuval Cohen
Algemeen Directeur bij CORBUS PHARMACEUTICALS HOLDINGS, INC.
Vermogen: 3 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Yuval Cohen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
Celsus Therapeutics Plc
 Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom.
12
| Extinct | Pharmaceuticals: Major | 12 |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Yuval Cohen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AGENUS INC. | Biotechnology | Corporate Officer/Principal | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AURA BIOSCIENCES, INC. | Biotechnology | Chairman | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| MORPHOSYS AG | Biotechnology | Director/Board Member | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
Promega Corp.
 Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Biotechnology | Corporate Officer/Principal | |
Charles Street Securities Europe LLP
 Charles Street Securities Europe LLP Investment ManagersFinance Charles Street Securities Europe LLP (Charles Street) is a private equity firm founded in 1984. The firm is headquartered in the London, United Kingdom. | Investment Managers | Private Equity Investor | |
| University of Cambridge | College/University | Graduate Degree Undergraduate Degree | |
| Babson College | College/University | Masters Business Admin Undergraduate Degree | |
| The Johns Hopkins University | College/University | Corporate Officer/Principal Director/Board Member | |
| The Hebrew University of Jerusalem | College/University | Graduate Degree Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Operating Officer Human Resources Officer Corporate Officer/Principal President | |
| NAVIOS MARITIME HOLDINGS INC. | Marine Shipping | Director/Board Member | |
| University of Strasbourg | College/University | Doctorate Degree Doctorate Degree | |
Vaccine Research International Plc
 Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Vaccine Research International Plc is a British company that focuses on conducting clinical trials to evaluate the effectiveness of vaccine SA75 in preventing staphylococcal infections in hospital patients and the wider community. | Miscellaneous Commercial Services | Director/Board Member | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ECHO THERAPEUTICS, INC. | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
Sepal Pharma Plc
 Sepal Pharma Plc Pharmaceuticals: MajorHealth Technology Sepal Pharma Plc is a British company that manufactures pharmaceutical preparations. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Zambia | College/University | Doctorate Degree | |
Insmed Ltd.
 Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| REDHILL BIOPHARMA LTD. | Pharmaceuticals: Major | Chief Operating Officer | |
Pierce Biotechnology, Inc.
 Pierce Biotechnology, Inc. BiotechnologyHealth Technology Part of Thermo Fisher Scientific, Inc., Pierce Biotechnology, Inc. is a company that offers a range of innovative, high-quality products for protein biology research. The company is based in Rockford, IL. The company's products include Pierce antibodies, SuperSignal chemiluminescent substrates, Pierce BCA protein assays, and other research tools and reagents. | Biotechnology | Corporate Officer/Principal | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO Chief Executive Officer Chief Executive Officer | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HLS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SHATTUCK LABS, INC. | Biotechnology | Chairman | |
Verseau Therapeutics, Inc.
 Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | Miscellaneous Commercial Services | Chairman | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Carrick Therapeutics UK Ltd.
 Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Carrick Therapeutics Ltd., Carrick Therapeutics UK Ltd. is a clinical-stage biopharmaceutical company based in Oxford, UK. Carrick Therapeutics translates in-house and in-licensed assets to target the most aggressive and resistant forms of cancer, working in combination with existing oncology drugs to address unmet patient needs. The British company focuses on developing innovative therapies to improve patient outcomes in oncological therapy. The company's therapies have potential in advanced breast, prostate, and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma. Timothy R. Pearson has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Chairman | |
| Droia Ventures | Corporate Officer/Principal | ||
Vidac Pharma Ltd.
 Vidac Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vidac Pharma Ltd. manufactures pharmaceutical products. It is a clinical stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases. The company was founded in 2011 by Max Herzberg is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Actio Biosciences, Inc.
 Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Actio Biosciences, Inc. is an American precision medicine company that focuses on developing new therapeutics for rare and common diseases by targeting shared genetics. Actio Biosciences was founded in October 2021 and is based in an undisclosed location. The company applies its expertise in genetics, drug discovery, and data sciences to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward potent and precisely targeted therapeutics. The company is led by leaders in genetics and drug development and backed by top healthcare investors. | Pharmaceuticals: Major | Chairman | |
Ananke Therapeutics, Inc.
 Ananke Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ananke Therapeutics, Inc. develops therapeutic medicines for patients. | Pharmaceuticals: Major | Chairman | |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
GRAIL LLC
 GRAIL LLC Medical/Nursing ServicesHealth Services GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Medical/Nursing Services | President |
Statistieken
Internationaal
| Verenigde Staten | 33 |
| Verenigd Koninkrijk | 9 |
| Israël | 5 |
| Duitsland | 2 |
| Kaaimaneilanden | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 4 |
| Transportation | 2 |
Operationeel
| Director/Board Member | 147 |
| Corporate Officer/Principal | 90 |
| Chairman | 41 |
| Independent Dir/Board Member | 39 |
| Director of Finance/CFO | 29 |
Sterkste connecties
| Insiders | |
|---|---|
| George Golumbeski | 36 |
| David Sidransky | 32 |
| Yiu Nam Lau | 26 |
| David Hochman | 26 |
| Allan Shaw | 23 |
| Paris Panayiotopoulos | 18 |
| Gur Roshwalb | 17 |
| Fredric D. Price | 16 |
| Jacques Suzanne | 15 |
| Alan G. Harris | 14 |
| Mark A. Tepper | 13 |
| Sean Moran | 13 |
| Christina Bertsch | 12 |
| Amos Eiran | 12 |
| Renu Gupta | 11 |
- Beurs
- Insiders
- Yuval Cohen
- Bedrijfsconnecties
